The Experts below are selected from a list of 414 Experts worldwide ranked by ideXlab platform
Peter Curtis - One of the best experts on this subject based on the ideXlab platform.
-
P02.55. Craniosacral Therapy for migraine: a feasibility study
BMC Complementary and Alternative Medicine, 2012Co-Authors: John Douglas Mann, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Peter CurtisAbstract:Methods Individuals with moderate to severe migraine were recruited from specialty clinics, family practices, and the university community. After confirmatory clinical evaluation and an 8-week run-in phase, those meeting study criteria (compliant with study procedures, at least 5 migraines per month) were randomized to 8 weekly CST or low-strength static magnet Therapy (LSSM) treatments. Study participants were followed for 4 weeks after the conclusion of Therapy. Primary outcome measures included headache frequency and headache-specific quality of life (HIT-6). Secondary headache-specific measures include headache-related disability (MIDAS), headache intensity, and abortive medication use.
-
Credibility of Low-Strength Static Magnet Therapy as an Attention Control Intervention for a Randomized Controlled Study of Craniosacral Therapy for Migraine Headaches
Journal of alternative and complementary medicine (New York N.Y.), 2011Co-Authors: Peter Curtis, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Jongbae Park, J. Douglas MannAbstract:Abstract Background: Developing valid control groups that generate similar perceptions and expectations to experimental complementary and alternative (CAM) treatments can be challenging. The perceived credibility of treatment and outcome expectancy often contributes to positive clinical responses to CAM therapies, thereby confounding efficacy data. As part of a clinical feasibility study, credibility and expectancy data were obtained from subjects suffering from migraine who received either Craniosacral Therapy (CST) or an attention-control, sham, and low-strength magnet (LSSM) intervention. Objective: The objective of this study was to evaluate whether the LSSM intervention generated similar levels of subject credibility and expectancy compared to CST. Design: This was a two-arm randomized controlled trial. Subjects: Sixty-five (65) adults with moderate to severe migraine were the subjects of this study. Interventions: After an 8-week baseline, subjects were randomized to eight weekly treatments of eithe...
-
Craniosacral Therapy for migraine: protocol development for an exploratory controlled clinical trial.
BMC complementary and alternative medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention.
-
Craniosacral Therapy for migraine: Protocol development for an exploratory controlled clinical trial
BMC Complementary and Alternative Medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan A GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention. Methods The trial is designed to test the hypothesis that, compared to those receiving usual care plus a treatment with low-strength static magnets (attention-control complementary Therapy), subjects receiving usual medical care plus CST will demonstrate significant improvement in: quality-of-life as measured by the Headache Impact Test (HIT-6); reduced frequency of migraine; and a perception of clinical benefit. Criteria for inclusion are either gender, age > 11, English or Spanish speaking, meeting the International Classification of Headache Disorders (ICHD) criteria for migraine with or without aura, a headache frequency of 5 to 15 per month over at least two years. After an 8 week baseline phase, eligible subjects are randomized to either CST or an attention control intervention, low strength static magnets (LSSM). To evaluate possible therapist bias, videotaped encounters are analyzed to assess for any systematic group differences in interactions with subjects. Results 169 individuals have been screened for eligibility, of which 109 were eligible for the study. Five did not qualify during the baseline phase because of inadequate headache frequency. Nineteen have withdrawn from the study after giving consent. Conclusion This report endorses the feasibility of undertaking a rigorous randomized clinical trial of CST for migraine using a standardized CST protocol and an innovative control protocol developed for the study. Subjects are able and willing to complete detailed headache diaries during an 8-week baseline period, with few dropouts during the study period, indicating the acceptability of both interventions. Trial Registration ClinicalTrials.gov NCT00665236
John E Upledger - One of the best experts on this subject based on the ideXlab platform.
-
Perspective Craniosacral Therapy PART II: AS IT IS TODAY
2016Co-Authors: John E UpledgerAbstract:In this, the second installment of a three part series on Craniosacral Therapy, I have discussed the status of Craniosacral Therapy as a treatment modality today. Also included in the discus sion are some of the reasons for its current status, political and control issues that have arisen, its clinical applications, its progeny and integration with other therapeutic approaches, and explorations that are currently underway
-
Perspective Craniosacral Therapy PART I: ITS ORIGINS AND DEVELOPMENT
2016Co-Authors: John E UpledgerAbstract:In this. the first installment of a series on Craniosacral Therapy and energy medicine, I have attempted to describe in brief the many facets of the system and Therapy as they presented themselves, almost simultaneously. The observations that led to the research into the Craniosacral system are described. The clinical and educational ramificarions are also considered. In the second and third installments, these two latter aspects will be considered in more detail. Political aspects and events which resulted from the release of Craniosacral Therapy to the healthcare community at latge and to the public will be described and discussed
-
Experimental THE EFFECTS OF UPLEDGER Craniosacral Therapy ON POST TRAUMATIC STRESS DISORDER SYMPTOMATOLOGY IN VIETNAM COMBAT VETERANS
2016Co-Authors: John E Upledger, O. M. M. Barry, S. KaplanAbstract:The Upledger Institute has provided rwo week intensive treatment for Vietnam veterans suffering from Post Traumatic Stress Disorder as diagnosed by the Veteran's Affairs (VA) medical division. These patients received psychological evaluation tests at the times of entry and exit into and out of the program. The intensive treatment was about six-seven hours per day for eight full days, with approximately three-four hours on the first and last days of the program. The Therapy used was primarily Craniosacral Therapy and its progeny Energy Cyst Release, SomatoEmotional Release and Therapeutic Imagery and Dialogue. The results obtained strongly suggest that PTSD may be more successfully treated when the thetapy includes corrections of the Craniosacral system, the release of foreign energies and conscious-nonconscious integration
-
THE EFFECTS OF UPLEDGER Craniosacral Therapy ON POST TRAUMATIC STRESS DISORDER SYMPTOMATOLOGY IN VIETNAM COMBAT VETERANS
Subtle Energies & Energy Medicine Journal Archives, 2000Co-Authors: John E Upledger, Barry S Kaplan, Russell A Bourne, Richard B ZondermanAbstract:The Upledger Institute has provided rwo week intensive treatment for Vietnam veterans suffering from Post Traumatic Stress Disorder as diagnosed by the Veteran's Affairs (VA) medical division. These patients received psychological evaluation tests at the times of entry and exit into and out of the program. The intensive treatment was about six-seven hours per day for eight full days, with approximately three-four hours on the first and last days of the program. The Therapy used was primarily Craniosacral Therapy and its progeny Energy Cyst Release, SomatoEmotional Release and Therapeutic Imagery and Dialogue. The results obtained strongly suggest that PTSD may be more successfully treated when the thetapy includes corrections of the Craniosacral system, the release of foreign energies and conscious-nonconscious integration.
-
cranial osteopathy and Craniosacral Therapy current opinions
Journal of Bodywork and Movement Therapies, 1998Co-Authors: A J Ferguson, John E Upledger, John M Mcpartland, M Collins, R LeverAbstract:Since the publication of The Cranial Bowl by William Sutherland DO in Minnesota in 1939 there has been considerable controversy within the osteopathic profession as to the existence of what he called the 'primary respiratory mechanism', and if it does exist then what are the physiological processes behind it. In the past 20 years Sutherland's hypothesis and practice have also been taught to non-osteopaths under the name of Craniosacral Therapy, principally by Dr John Upledger DO and the Upledger Institute in Florida. Nearly 60 years later the debate continues and, despite improvements in the understanding of human physiology, the teaching of cranial osteopathy has hardly changed. JBMT considered that now was a good time to ask two osteopaths in the USA, Drs Upledger and John McPartland, and two in the UK, Robert Lever and Dr Martin Collins to give their views in the light of contemporary knowledge. Each osteopath has studied and experienced the cranial phenomenon, so there are no strong contrary opinions as to its existence; rather these are individual explanations of it. Each was given the same five questions to answer in their own words and their answers are printed here for readers to form their own ideas. The questions are:
Laurel Wilkinson - One of the best experts on this subject based on the ideXlab platform.
-
P02.55. Craniosacral Therapy for migraine: a feasibility study
BMC Complementary and Alternative Medicine, 2012Co-Authors: John Douglas Mann, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Peter CurtisAbstract:Methods Individuals with moderate to severe migraine were recruited from specialty clinics, family practices, and the university community. After confirmatory clinical evaluation and an 8-week run-in phase, those meeting study criteria (compliant with study procedures, at least 5 migraines per month) were randomized to 8 weekly CST or low-strength static magnet Therapy (LSSM) treatments. Study participants were followed for 4 weeks after the conclusion of Therapy. Primary outcome measures included headache frequency and headache-specific quality of life (HIT-6). Secondary headache-specific measures include headache-related disability (MIDAS), headache intensity, and abortive medication use.
-
Credibility of Low-Strength Static Magnet Therapy as an Attention Control Intervention for a Randomized Controlled Study of Craniosacral Therapy for Migraine Headaches
Journal of alternative and complementary medicine (New York N.Y.), 2011Co-Authors: Peter Curtis, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Jongbae Park, J. Douglas MannAbstract:Abstract Background: Developing valid control groups that generate similar perceptions and expectations to experimental complementary and alternative (CAM) treatments can be challenging. The perceived credibility of treatment and outcome expectancy often contributes to positive clinical responses to CAM therapies, thereby confounding efficacy data. As part of a clinical feasibility study, credibility and expectancy data were obtained from subjects suffering from migraine who received either Craniosacral Therapy (CST) or an attention-control, sham, and low-strength magnet (LSSM) intervention. Objective: The objective of this study was to evaluate whether the LSSM intervention generated similar levels of subject credibility and expectancy compared to CST. Design: This was a two-arm randomized controlled trial. Subjects: Sixty-five (65) adults with moderate to severe migraine were the subjects of this study. Interventions: After an 8-week baseline, subjects were randomized to eight weekly treatments of eithe...
-
Craniosacral Therapy for migraine: protocol development for an exploratory controlled clinical trial.
BMC complementary and alternative medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention.
-
Craniosacral Therapy for migraine: Protocol development for an exploratory controlled clinical trial
BMC Complementary and Alternative Medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan A GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention. Methods The trial is designed to test the hypothesis that, compared to those receiving usual care plus a treatment with low-strength static magnets (attention-control complementary Therapy), subjects receiving usual medical care plus CST will demonstrate significant improvement in: quality-of-life as measured by the Headache Impact Test (HIT-6); reduced frequency of migraine; and a perception of clinical benefit. Criteria for inclusion are either gender, age > 11, English or Spanish speaking, meeting the International Classification of Headache Disorders (ICHD) criteria for migraine with or without aura, a headache frequency of 5 to 15 per month over at least two years. After an 8 week baseline phase, eligible subjects are randomized to either CST or an attention control intervention, low strength static magnets (LSSM). To evaluate possible therapist bias, videotaped encounters are analyzed to assess for any systematic group differences in interactions with subjects. Results 169 individuals have been screened for eligibility, of which 109 were eligible for the study. Five did not qualify during the baseline phase because of inadequate headache frequency. Nineteen have withdrawn from the study after giving consent. Conclusion This report endorses the feasibility of undertaking a rigorous randomized clinical trial of CST for migraine using a standardized CST protocol and an innovative control protocol developed for the study. Subjects are able and willing to complete detailed headache diaries during an 8-week baseline period, with few dropouts during the study period, indicating the acceptability of both interventions. Trial Registration ClinicalTrials.gov NCT00665236
Remy R Coeytaux - One of the best experts on this subject based on the ideXlab platform.
-
P02.55. Craniosacral Therapy for migraine: a feasibility study
BMC Complementary and Alternative Medicine, 2012Co-Authors: John Douglas Mann, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Peter CurtisAbstract:Methods Individuals with moderate to severe migraine were recruited from specialty clinics, family practices, and the university community. After confirmatory clinical evaluation and an 8-week run-in phase, those meeting study criteria (compliant with study procedures, at least 5 migraines per month) were randomized to 8 weekly CST or low-strength static magnet Therapy (LSSM) treatments. Study participants were followed for 4 weeks after the conclusion of Therapy. Primary outcome measures included headache frequency and headache-specific quality of life (HIT-6). Secondary headache-specific measures include headache-related disability (MIDAS), headache intensity, and abortive medication use.
-
Credibility of Low-Strength Static Magnet Therapy as an Attention Control Intervention for a Randomized Controlled Study of Craniosacral Therapy for Migraine Headaches
Journal of alternative and complementary medicine (New York N.Y.), 2011Co-Authors: Peter Curtis, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Jongbae Park, J. Douglas MannAbstract:Abstract Background: Developing valid control groups that generate similar perceptions and expectations to experimental complementary and alternative (CAM) treatments can be challenging. The perceived credibility of treatment and outcome expectancy often contributes to positive clinical responses to CAM therapies, thereby confounding efficacy data. As part of a clinical feasibility study, credibility and expectancy data were obtained from subjects suffering from migraine who received either Craniosacral Therapy (CST) or an attention-control, sham, and low-strength magnet (LSSM) intervention. Objective: The objective of this study was to evaluate whether the LSSM intervention generated similar levels of subject credibility and expectancy compared to CST. Design: This was a two-arm randomized controlled trial. Subjects: Sixty-five (65) adults with moderate to severe migraine were the subjects of this study. Interventions: After an 8-week baseline, subjects were randomized to eight weekly treatments of eithe...
-
Craniosacral Therapy for migraine: protocol development for an exploratory controlled clinical trial.
BMC complementary and alternative medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention.
-
Craniosacral Therapy for migraine: Protocol development for an exploratory controlled clinical trial
BMC Complementary and Alternative Medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan A GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention. Methods The trial is designed to test the hypothesis that, compared to those receiving usual care plus a treatment with low-strength static magnets (attention-control complementary Therapy), subjects receiving usual medical care plus CST will demonstrate significant improvement in: quality-of-life as measured by the Headache Impact Test (HIT-6); reduced frequency of migraine; and a perception of clinical benefit. Criteria for inclusion are either gender, age > 11, English or Spanish speaking, meeting the International Classification of Headache Disorders (ICHD) criteria for migraine with or without aura, a headache frequency of 5 to 15 per month over at least two years. After an 8 week baseline phase, eligible subjects are randomized to either CST or an attention control intervention, low strength static magnets (LSSM). To evaluate possible therapist bias, videotaped encounters are analyzed to assess for any systematic group differences in interactions with subjects. Results 169 individuals have been screened for eligibility, of which 109 were eligible for the study. Five did not qualify during the baseline phase because of inadequate headache frequency. Nineteen have withdrawn from the study after giving consent. Conclusion This report endorses the feasibility of undertaking a rigorous randomized clinical trial of CST for migraine using a standardized CST protocol and an innovative control protocol developed for the study. Subjects are able and willing to complete detailed headache diaries during an 8-week baseline period, with few dropouts during the study period, indicating the acceptability of both interventions. Trial Registration ClinicalTrials.gov NCT00665236
Chirayath M. Suchindran - One of the best experts on this subject based on the ideXlab platform.
-
P02.55. Craniosacral Therapy for migraine: a feasibility study
BMC Complementary and Alternative Medicine, 2012Co-Authors: John Douglas Mann, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Peter CurtisAbstract:Methods Individuals with moderate to severe migraine were recruited from specialty clinics, family practices, and the university community. After confirmatory clinical evaluation and an 8-week run-in phase, those meeting study criteria (compliant with study procedures, at least 5 migraines per month) were randomized to 8 weekly CST or low-strength static magnet Therapy (LSSM) treatments. Study participants were followed for 4 weeks after the conclusion of Therapy. Primary outcome measures included headache frequency and headache-specific quality of life (HIT-6). Secondary headache-specific measures include headache-related disability (MIDAS), headache intensity, and abortive medication use.
-
Credibility of Low-Strength Static Magnet Therapy as an Attention Control Intervention for a Randomized Controlled Study of Craniosacral Therapy for Migraine Headaches
Journal of alternative and complementary medicine (New York N.Y.), 2011Co-Authors: Peter Curtis, Susan Gaylord, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Rebecca S Coble, Jongbae Park, J. Douglas MannAbstract:Abstract Background: Developing valid control groups that generate similar perceptions and expectations to experimental complementary and alternative (CAM) treatments can be challenging. The perceived credibility of treatment and outcome expectancy often contributes to positive clinical responses to CAM therapies, thereby confounding efficacy data. As part of a clinical feasibility study, credibility and expectancy data were obtained from subjects suffering from migraine who received either Craniosacral Therapy (CST) or an attention-control, sham, and low-strength magnet (LSSM) intervention. Objective: The objective of this study was to evaluate whether the LSSM intervention generated similar levels of subject credibility and expectancy compared to CST. Design: This was a two-arm randomized controlled trial. Subjects: Sixty-five (65) adults with moderate to severe migraine were the subjects of this study. Interventions: After an 8-week baseline, subjects were randomized to eight weekly treatments of eithe...
-
Craniosacral Therapy for migraine: protocol development for an exploratory controlled clinical trial.
BMC complementary and alternative medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention.
-
Craniosacral Therapy for migraine: Protocol development for an exploratory controlled clinical trial
BMC Complementary and Alternative Medicine, 2008Co-Authors: John Douglas Mann, K Faurot, Chirayath M. Suchindran, Remy R Coeytaux, Laurel Wilkinson, Peter Curtis, Susan A GaylordAbstract:Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral Therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM) as an attention control intervention. Methods The trial is designed to test the hypothesis that, compared to those receiving usual care plus a treatment with low-strength static magnets (attention-control complementary Therapy), subjects receiving usual medical care plus CST will demonstrate significant improvement in: quality-of-life as measured by the Headache Impact Test (HIT-6); reduced frequency of migraine; and a perception of clinical benefit. Criteria for inclusion are either gender, age > 11, English or Spanish speaking, meeting the International Classification of Headache Disorders (ICHD) criteria for migraine with or without aura, a headache frequency of 5 to 15 per month over at least two years. After an 8 week baseline phase, eligible subjects are randomized to either CST or an attention control intervention, low strength static magnets (LSSM). To evaluate possible therapist bias, videotaped encounters are analyzed to assess for any systematic group differences in interactions with subjects. Results 169 individuals have been screened for eligibility, of which 109 were eligible for the study. Five did not qualify during the baseline phase because of inadequate headache frequency. Nineteen have withdrawn from the study after giving consent. Conclusion This report endorses the feasibility of undertaking a rigorous randomized clinical trial of CST for migraine using a standardized CST protocol and an innovative control protocol developed for the study. Subjects are able and willing to complete detailed headache diaries during an 8-week baseline period, with few dropouts during the study period, indicating the acceptability of both interventions. Trial Registration ClinicalTrials.gov NCT00665236